PRECISION OPTICS CORPORATION, INC.
POCINasdaqHealthcare · Electromedical & Electrotherapeutic Apparatus · MA · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $19.1M | $19.1M | $21.0M | $15.7M | $10.7M | $9.9M |
| Operating income | −$5.6M | −$2.7M | −$638,548 | −$1.5M | −$905,583 | −$1.4M |
| Net income | −$5.8M | −$3.0M | −$144,613 | −$928,416 | −$102,835 | −$1.4M |
| Total assets | $19.8M | $16.9M | $19.7M | $16.7M | $6.3M | $6.4M |
| Total liabilities | $7.5M | $6.8M | $7.7M | — | — | — |
| Equity | $12.3M | $10.1M | $12.0M | $9.0M | $3.4M | $2.8M |
| EPS (diluted) | $-0.85 | $-0.49 | $-0.03 | $-0.18 | $-0.01 | — |
| Shares out. | 7.7M | 6.4M | 6.1M | 16.9M | 13.3M | 13.2M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −29.1%
- Net margin
- −30.3%
- Return on equity
- −47.2%
- Return on assets
- −29.2%
- Return on capital (ROCE)
- −40.7%
- Liabilities / assets
- 38.1%
- Debt / equity
- 0.61×
- Book value / share
- $1.59
- Revenue growth (YoY)
- −0.1%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -8.27distress
- Accruals / assets
- −11.3%clean
- Beneish M-Score
- -2.47normal
- Piotroski F-Score
- 3/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 4 warning● 2 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- Negative operating cash flow
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Sep 28, 2015
- NT 10-Kmissed a reporting deadline ↗Sep 28, 2012
- NT 10-Kmissed a reporting deadline ↗Sep 28, 2006
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Needham Investment Management LlcPassive (13G)May 14, 2026
- Pessin Norman HActivist (13D)Mar 31, 2026
- Teller Richard EPassive (13G)Nov 21, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Coll Wayne MOfficer — Chief Financial Officer | Mar 31, 2026 | Grant | 1,568 | $3.98 |
| Coll Wayne MOfficer — Chief Financial Officer | Mar 30, 2026 | Buy | 20,833 | $3.60 |
| Forkey Joseph NormanOfficer — Chief Executive Officer | Mar 30, 2026 | Buy | 1,388 | $3.60 |
| Traut JosephOfficer — Chief Operating Officer | Mar 30, 2026 | Buy | 41,666 | $3.60 |
| Miclot Andrew J.Director | Mar 12, 2026 | Option exercise | 20,000 | $1.44 |
| Coll Wayne MOfficer — Chief Financial Officer | Mar 31, 2025 | Grant | 1,333 | $6250.00 |
| Woodward Peter HDirector | May 16, 2025 | Option exercise | 30,000 | $2.19 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 24,673 | 1.0 | -5.0% |
| Apr 30, 2026 | 25,964 | 1.0 | +22.6% |
| Apr 15, 2026 | 21,176 | 1.0 | -20.2% |
| Mar 31, 2026 | 26,535 | 1.0 | +712.2% |
| Mar 13, 2026 | 3,267 | 1.0 | -51.4% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Entered a material agreement · Unregistered equity sale · Other material eventMar 30, 2026
- Shareholder voteMar 20, 2026
- Director / officer changeOct 3, 2025
- Entered a material agreementJun 3, 2025
- Shareholder voteMay 23, 2025
- Entered a material agreementMay 20, 2025
- Entered a material agreementMay 19, 2025
- Director / officer changeMar 20, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SCHEDULE 13G/AMay 14, 2026
- 10-QFORM 10-Q FOR MAR 2026May 13, 2026
- 3May 6, 2026
- 3Apr 6, 2026
- 4Apr 2, 2026
- 4Apr 1, 2026
- 4Apr 1, 2026
- 4Apr 1, 2026
- SCHEDULE 13D/AMar 31, 2026
- 8-KFORM 8-KMar 30, 2026
- 424B5424B5 PROSPECTUS SUPPLEMENTMar 30, 2026
- 424B5424B5 PROSPECTUS SUPPLEMENTMar 26, 2026
- 8-KCURRENT REPORTMar 20, 2026
- 4Mar 16, 2026
- 10-QFORM 10-Q FOR DEC 2025Feb 17, 2026
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.